FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067703 [Registered on: 21/05/2024] Trial Registered Prospectively
Last Modified On: 15/05/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Siddha
Other (Specify) [THOKKANAM]  
Study Design  Non-randomized, Multiple Arm Trial 
Public Title of Study   To study the effect of Siddha formulations Vani vallarai Nei (Internal) and Chitramutti Madakuthylam (External) for Cerebral palsy  
Scientific Title of Study   Pre-Clinical and Clinical Studies On the management Of Cerebral Palsy (Sirakamba Vatham) in Children Using The Siddha Formulations Vani Vallarai Nei (Internal) and Chitramutti Madakuthylam (External) – A Multi centric study  
Trial Acronym  Not Applicable 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S Shakila 
Designation  Full Time PhD scholar, 
Affiliation  National Institute of Siddha,  
Address  Department of Kuzhanthai Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai- 600 047.

Chennai
TAMIL NADU
600047
India 
Phone  9789018413  
Fax    
Email  sakila.sekar19@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S Shakila 
Designation  Full Time PhD scholar, 
Affiliation  National Institute of Siddha,  
Address  Department of Kuzhanthai Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai- 600 047.


TAMIL NADU
600047
India 
Phone  9789018413  
Fax    
Email  sakila.sekar19@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S Shakila 
Designation  Full Time PhD scholar, 
Affiliation  National Institute of Siddha,  
Address  Department of Kuzhanthai Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai- 600 047.


TAMIL NADU
600047
India 
Phone  9789018413  
Fax    
Email  sakila.sekar19@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Siddha 
 
Primary Sponsor  
Name  National Institute of Siddha,  
Address  Department of Kuzhanthai Maruthuvam National Institute of Siddha Tambaram Sanatorium Chennai- 600 047  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr P Arul mozhi  Ayothidoss Pandithar Hospital attached with National Institute of Siddha  Room No 17 Department of Kuzhanthai Maruthuvam National Institute of Siddha Tambaram Sanatorium Chennai 600 047
Kancheepuram
TAMIL NADU 
9500151930

drarulmozhi2012@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G804||Ataxic cerebral palsy, (2) ICD-10 Condition: G809||Cerebral palsy, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  physiotherapy   only for comparison purpose  
Intervention  Vani vallarai Nei (Internal) and Chitramutti Madakuthylam (External)  Dose: 3yrs to 5 yrs - 6 ml , 6yrs to 9yrs - 9 ml , 10yrs to 12 yrs - 11 ml 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Diagnosis of Spastic type of cerebral palsy (Sirakamba vadham)

Parents/Guardians giving informed consent (signed witnessed, according to local regulations) before any protocol specific procedures. 
 
ExclusionCriteria 
Details  K/C/O Ataxic/ Dyskinetic /Athetoid/ choreoathetoid / dystonic CP
Mixed type of Cerebral Palsy
CP child with Spinal deformities
ASD/ADHD(Hyper activity)
Blindness, Down Syndrome, Spina Bifida, Traumatic Brain Injury
Severe and/or Multiple Disabilities & Children with H/o bleeding tendencies, cirrhosis and oesophageal Varices
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Safety and efficacy of the trial drug will be analyzed by Preclinical studies.
Improvements in the Clinical conditions will be measured by Assessment scale.
 
90 days  
 
Secondary Outcome  
Outcome  TimePoints 
Intervention efficacy assessed by the Siddha Diagnostic parameter.   90 days 
 
Target Sample Size   Total Sample Size="186"
Sample Size from India="186" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Cerebral palsy places a heavy burden on families and health systems. This is an open-label, non-randomized control study on Cerebral palsy (Sirakamba Vatham) to evaluate the official Siddha formulations Vani Vallarai Nei (internal) and Chitramutti Madakuthylam (external). The children took internal (twice a day) and external (once a day) medicines for 90 days, and improvement will be compared for the control group. The present study  will provide a better direction by improving the quality of life of children and their life expectancy.
 
Close